Clinical trial Recruiting at 1 site Interventional Ages 18 to 55

Intracranial Mapping of Cortical Control of Breathing in Epilepsy

Official title: Intracranial CArtography of Cortical Contribution to Respiratory Load Compensation in Epilepsy

Run by Hospices Civils de Lyon · NCT07599150 · Data updated 2026-11-12

This study tests whether targeted brain area activity during SEEG can reveal how the cortex helps regulate breathing in people with drug-resistant epilepsy.

More Epilepsy trials

Quick facts

Study typeInterventional
Ages18 Years to 55 Years
SexAll
Enrollment20 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations1 site (Bron, Rhone)
StatusRecruiting
StartedSeptember 17, 2026
Main results expectedSeptember 17, 2028
Study endsSeptember 17, 2028
Registry record updatedSeptember 23, 2026
Trial IDNCT07599150 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–55 with drug-resistant focal epilepsy undergoing SEEG with electrodes in perisylian and premotor cortex.

Probably not a fit

Patients without the specified SEEG electrode localization or those not undergoing presurgical evaluation may not benefit from this research.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study uses SEEG monitoring along with comprehensive respiratory and cardio-respiratory monitoring to examine how cortical regions contribute to breathing control during epileptic activity. Participants are adults with drug-resistant focal epilepsy undergoing presurgical evaluation, with SEEG electrodes in perisylvian and premotor areas. The protocol includes expiratory load challenges and hypercapnic tests to assess respiratory responses. Results could improve understanding of SUDEP risk and inform preventive strategies during the post-ictal period.

Why it matters

Potential benefit: If successful, the findings could guide better monitoring and interventions to prevent post-ictal breathing impairment in epilepsy.

How similar studies have gone: Previous studies suggest cortical involvement in breathing control, but this specific intracranial mapping approach is novel in epilepsy-related respiratory research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Written informed consent obtained from study subject and ability for study subject to comply with the requirements of the study
2. Aged 18 to 55 years old
3. Diagnosis of drug-resistant focal epilepsy, as defined by the International League Against Epilepsy 20
4. Patients undergoing SEEG as part of presurgical evaluation
5. At least one SEEG electrode localized in the perisylvian cortex
6. At least one SEEG electrode localized in the premotor cortex

Exclusion Criteria:

1\. Ongoing or chronic respiratory and/or cardiac insufficiency and/or ischemic cardiac disease 2. History of stroke in the last 5 years 3. Intracranial hypertension related to space-occupying lesion in the brain 4. Pregnant, parturient, or breastfeeding women 5. Individuals receiving psychiatric care 6. Individuals deprived of their liberty by judicial or administrative decision 7. Adults subject to legal protection measures (guardianship, curatorship) 8. Individuals not affiliated with a social security scheme or beneficiaries of a similar scheme

\-

Where it's running

  • Service de Neurologie Fonctionne et d'Epileptologie Hôpital Neurologique Pierre WERTHEIMER
    Bron, Rhone, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.